Nagy M Aurel, Cunnane Mary E, Juliano Amy F, Wiggs Janey L, Caruso Paul A, Gaier Eric D
Harvard Medical School (MAN, MEC, AFJ, JLW, EDG), Boston, Massachusetts; Department of Ophthalmology (MAN), University of California San Francisco, California; Departments of Radiology (MEC, AFJ) and Ophthalmology (JLW, EDG), Massachusetts Eye and Ear, Boston, Massachusetts; Neuroradiology Division (PAC), Lenox Hill Radiology and Medical Imaging Associates, RadNet, New York, New York; Department of Ophthalmology (EDG), Boston Children's Hospital, Boston, Massachusetts; and Picower Institute for Learning and Memory (EDG), Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts.
J Neuroophthalmol. 2025 Jun 1;45(2):145-152. doi: 10.1097/WNO.0000000000002191. Epub 2024 Jun 17.
Genetic optic atrophies comprise phenotypically heterogenous disorders of mitochondrial function. We aimed to correlate quantitative neuroimaging findings of the optic nerves in these disorders with clinical measures.
From a retrospective database of 111 patients with bilateral optic atrophy referred for genetic testing, 15 patients diagnosed with nonglaucomatous optic atrophy of genetic origin (7 patients with pathogenic variants in OPA1 , 3 patients with Wolfram syndrome, and 5 patients with Leber hereditary optic neuropathy) who had accessible magnetic resonance (MR) images of the orbits and/or brain were analyzed. The primary outcome measures of T2 short Tau inversion recovery (STIR) signal and optic nerve caliber were quantified according to a standardized protocol, normalized to internal standards, and compared between cases and controls. Inter-rater reliability was assessed and clinical features were analyzed according to MRI features.
Compared with control patients, the 15 genetic optic atrophy patients demonstrated significantly increased T2 STIR signal (fold-change 1.6, P = 0.0016) and decreased optic nerve caliber (fold-change 0.72, P = 0.00012) after internal normalization. These metrics were reliable (inter-reader reliability correlation coefficients of 0.98 [ P = 0.00036] and 0.74 [ P = 0.0025] for normalized STIR and nerve caliber, respectively) and significantly correlated with visual acuity, cup-to-disc ratio, and visual field testing.
Normalized optic nerve STIR signal and optic nerve caliber significantly correlate with visual acuity, cup-to-disc ratio, and perimetric performance in patients with genetic optic atrophy. A formalized protocol to characterize these differences on MRI may help to guide accurate and expedient diagnostic evaluation.
遗传性视神经萎缩包括线粒体功能的表型异质性疾病。我们旨在将这些疾病中视神经的定量神经影像学结果与临床指标相关联。
从一个针对111例双侧视神经萎缩患者进行基因检测的回顾性数据库中,分析了15例被诊断为遗传性非青光眼性视神经萎缩的患者(7例OPA1基因有致病性变异,3例患有沃夫勒姆综合征,5例患有Leber遗传性视神经病变),这些患者可获取眼眶和/或脑部的磁共振(MR)图像。根据标准化方案对T2短tau反转恢复(STIR)信号和视神经管径的主要结局指标进行量化,以内标进行标准化,并在病例组和对照组之间进行比较。评估了阅片者间的可靠性,并根据MRI特征分析了临床特征。
与对照患者相比,15例遗传性视神经萎缩患者在进行内标标准化后,T2 STIR信号显著增加(变化倍数为1.6,P = 0.0016),视神经管径减小(变化倍数为0.72,P = 0.00012)。这些指标具有可靠性(标准化STIR和神经管径的阅片者间可靠性相关系数分别为0.98 [P = 0.00036]和0.74 [P = 0.0025]),并且与视力、杯盘比和视野检查显著相关。
在遗传性视神经萎缩患者中,标准化的视神经STIR信号和视神经管径与视力、杯盘比和视野检查结果显著相关。一种用于在MRI上表征这些差异的规范化方案可能有助于指导准确、便捷的诊断评估。